Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche
Neurodegenerative disorders are one of the leading causes of death and disability and one of the biggest burdens on health care systems. Novel approaches using various types of stem cells have been proposed to treat common neurodegenerative disorders such as Alzheimer’s Disease, Parkinson’s Disease,...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/5736059 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832553040644669440 |
---|---|
author | Alejandro Luarte Luis Federico Bátiz Ursula Wyneken Carlos Lafourcade |
author_facet | Alejandro Luarte Luis Federico Bátiz Ursula Wyneken Carlos Lafourcade |
author_sort | Alejandro Luarte |
collection | DOAJ |
description | Neurodegenerative disorders are one of the leading causes of death and disability and one of the biggest burdens on health care systems. Novel approaches using various types of stem cells have been proposed to treat common neurodegenerative disorders such as Alzheimer’s Disease, Parkinson’s Disease, or stroke. Moreover, as the secretome of these cells appears to be of greater benefit compared to the cells themselves, the extracellular components responsible for its therapeutic benefit have been explored. Stem cells, as well as most cells, release extracellular vesicles such as exosomes, which are nanovesicles able to target specific cell types and thus to modify their function by delivering proteins, lipids, and nucleic acids. Exosomes have recently been tested in vivo and in vitro as therapeutic conveyors for the treatment of diseases. As such, they could be engineered to target specific populations of cells within the CNS. Considering the fact that many degenerative brain diseases have an impact on adult neurogenesis, we discuss how the modulation of the adult neurogenic niches may be a therapeutic target of stem cell-derived exosomes. These novel approaches should be examined in cellular and animal models to provide better, more effective, and specific therapeutic tools in the future. |
format | Article |
id | doaj-art-261b82b21bcc4936bf6b436637bd6891 |
institution | Kabale University |
issn | 1687-966X 1687-9678 |
language | English |
publishDate | 2016-01-01 |
publisher | Wiley |
record_format | Article |
series | Stem Cells International |
spelling | doaj-art-261b82b21bcc4936bf6b436637bd68912025-02-03T05:57:07ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/57360595736059Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic NicheAlejandro Luarte0Luis Federico Bátiz1Ursula Wyneken2Carlos Lafourcade3Laboratorio de Neurociencias, Facultad de Medicina, Universidad de Los Andes, Monseñor Alvaro del Portillo 12455, Las Condes, 7550000 Santiago, ChileCenter for Interdisciplinary Studies on the Nervous System (CISNe), Universidad Austral de Chile, Valdivia, ChileLaboratorio de Neurociencias, Facultad de Medicina, Universidad de Los Andes, Monseñor Alvaro del Portillo 12455, Las Condes, 7550000 Santiago, ChileLaboratorio de Neurociencias, Facultad de Medicina, Universidad de Los Andes, Monseñor Alvaro del Portillo 12455, Las Condes, 7550000 Santiago, ChileNeurodegenerative disorders are one of the leading causes of death and disability and one of the biggest burdens on health care systems. Novel approaches using various types of stem cells have been proposed to treat common neurodegenerative disorders such as Alzheimer’s Disease, Parkinson’s Disease, or stroke. Moreover, as the secretome of these cells appears to be of greater benefit compared to the cells themselves, the extracellular components responsible for its therapeutic benefit have been explored. Stem cells, as well as most cells, release extracellular vesicles such as exosomes, which are nanovesicles able to target specific cell types and thus to modify their function by delivering proteins, lipids, and nucleic acids. Exosomes have recently been tested in vivo and in vitro as therapeutic conveyors for the treatment of diseases. As such, they could be engineered to target specific populations of cells within the CNS. Considering the fact that many degenerative brain diseases have an impact on adult neurogenesis, we discuss how the modulation of the adult neurogenic niches may be a therapeutic target of stem cell-derived exosomes. These novel approaches should be examined in cellular and animal models to provide better, more effective, and specific therapeutic tools in the future.http://dx.doi.org/10.1155/2016/5736059 |
spellingShingle | Alejandro Luarte Luis Federico Bátiz Ursula Wyneken Carlos Lafourcade Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche Stem Cells International |
title | Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche |
title_full | Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche |
title_fullStr | Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche |
title_full_unstemmed | Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche |
title_short | Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche |
title_sort | potential therapies by stem cell derived exosomes in cns diseases focusing on the neurogenic niche |
url | http://dx.doi.org/10.1155/2016/5736059 |
work_keys_str_mv | AT alejandroluarte potentialtherapiesbystemcellderivedexosomesincnsdiseasesfocusingontheneurogenicniche AT luisfedericobatiz potentialtherapiesbystemcellderivedexosomesincnsdiseasesfocusingontheneurogenicniche AT ursulawyneken potentialtherapiesbystemcellderivedexosomesincnsdiseasesfocusingontheneurogenicniche AT carloslafourcade potentialtherapiesbystemcellderivedexosomesincnsdiseasesfocusingontheneurogenicniche |